https://www.livemint.com/news/india/biocon-biologics-expects-to-conclude-merger-with-viatris-biosimilars-portfolio-in-fy24-ceo-says-11691776143503.html
0
0
8/11/23 at 5:49pm
Organization
Livemint
Author
Ranjani Raghavan
33 words
0
Comments
Biocon closed its $3.34 billion acquisition of the global biosimilar portfolio of Viatris in November 2022 in a cash and equity deal
You are the first to view
Create an account
or login to join the discussion